Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Korea SE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Samsung Pharmaceutical Co Ltd

+ Add to Watchlist

001360:KS

6,270 KRW 70 1.10%

As of 02:29:08 ET on 04/01/2015.

Snapshot for Samsung Pharmaceutical Co Ltd (001360)

Open: 6,230 Day's Range: 5,700 - 6,540 Volume: 1,745,267
Previous Close: 6,340 52wk Range: 2,045 - 6,700 1-Yr Rtn: +109.35%

Stock Chart for 001360

No chart data available.
  • 001360:KS 6,270
  • 1D
  • 1M
  • 1Y
6,340
Interactive 001360 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 001360

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. KOSPI -
Earnings Per Share (ttm) -1,175.0000
Est. EPS -
Est. PEG Ratio -
Market Cap (M KRW) 150,308.79
Shares Outstanding (M) 23.97
30 Day Average Volume 861,956
Price/Book (mrq) 6.1422
Price/Sale (ttm) 3.0613
Dividend Indicated Gross Yield -%
Cash Dividend (KRW) -
Dividend Ex-Date 01/04/2000
5 Year Dividend Growth -
Next Earnings Announcement 05/15/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 001360

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 001360

Samsung Pharmaceutical Co., Ltd. manufactures medicines to treat a variety of diseases. The Company's products include medicines for inflammatory, nutrition, and digestive system.

Kim Won-KyuChairman/CEO/Rep DirectorPark Chul-JoonExecutive Director
Kim Jong-WooExecutive Director
More Company Profile & Key Executives for 001360

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil